(Total Views: 88)
Posted On: 12/05/2023 1:10:47 PM
Post# of 89220
$BOLT News Article - Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu https://marketwirenews.com/news-releases/bolt...32838.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
